Scinovex
review Open AccessTop 10% cited

Bone loss in inflammatory disorders

Journal of Endocrinology · 2009 · Vol. 201(3) · pp. 309–320
Rowan HardyMark S. Cooper

Abstract

Chronic inflammatory diseases of almost any cause are associated with bone loss. Bone loss is due to direct effects of inflammation, poor nutrition, reduced lean body mass, immobility and the effects of treatments, especially glucocorticoids. These mechanisms are complex and interrelated but are ultimately mediated through effects on the bone remodelling cycle. Inflammatory disease can increase bone resorption, decrease bone formation but most commonly impacts on both of these processes resulting in an uncoupling of bone formation from resorption in favour of excess resorption. This review will illustrate these interactions between inflammation and bone metabolism and discuss how these are, and might be, manipulated as therapies for inflammation related bone loss.

Bone Metabolism and DiseasesBone health and treatmentsBone health and osteoporosis researchBone resorptionInflammationEndocrinologyBone remodelingInternal medicineMedicineResorptionOsteoporosisBone massBone remodeling period

MeSH terms

AnimalsBone ResorptionGlucocorticoidsHumansImmobilizationInflammationModels, BiologicalNutritional Physiological PhenomenaGonadal Steroid HormonesBone Remodeling

Funding

  • GlaxoSmithKline
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Bone loss in inflammatory disorders · Scinovex